FrancophonIA/ELRC3.0 huggingface dataset:
English: Page 2
Slovenian: 2. stran
English: Page 36
Slovenian: 36. stran
English: Page 35
Slovenian: 35. stran
English: What you need to know before you take Uptravi
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Uptravi Ne jemljite zdravila Uptravi
English: If, for any reason, you stop taking Uptravi for more than 3 consecutive days (if you missed 6 doses in a row), contact your PAH doctor or nurse immediately as your dose may need to be adjusted to avoid side effects.
Slovenian: 6 odmerkov zaporedoma), se takoj obrnite na svojega zdravnika ali medicinsko sestro za PAH, saj je treba vaš odmerek morda prilagoditi, da se preprečijo neželeni učinki.
English: Page 22
Slovenian: 22. stran
English: Talk to your PAH doctor or nurse if you are taking any of the following medicines: - Gemfibrozil (medicine used to lower the level of fats [lipids] in the blood) - Clopidogrel (medicine used to inhibit blood clots in coronary artery disease) - Deferasirox (medicine used to remove iron from the blood stream) - Teriflunomide (medicine used to treat relapsing-remitting multiple sclerosis) - Carbamazepine (medicine used to treat some forms of epilepsy, nerve pain or to help control serious mood disorders when some other medicines do not work) - Phenytoin (medicine used to treat epilepsy) - Valproic acid (medicine used to treat epilepsy) - Probenecid (medicine used to treat gout) - Fluconazole, rifampicin or rifapentine (antibiotics used to treat infections)
Slovenian: - karbamazepin (zdravilo za zdravljenje nekaterih oblik epilepsije, bolečine živcev in za pomoč pri nadzoru resnih motenj razpoloženja, kadar nekatera druga zdravila ne delujejo) - fenitoin (zdravilo za zdravljenje epilepsije) - valprojska kislina (zdravilo za zdravljenje epilepsije) - probenecid (zdravilo za zdravljenje protina)
English: Page 16
Slovenian: 16. stran
English: Page 7
Slovenian: 7. stran
English: During dose titration some adverse reactions, reflecting the mode of action of Uptravi (such as headache, diarrhoea, nausea and vomiting, jaw pain, myalgia, pain in extremity, arthralgia, and flushing), may occur.
Slovenian: Med titriranjem odmerka se lahko pojavijo nekateri neželeni učinki zaradi načina delovanja zdravila Uptravi (kot so glavobol, driska, navzea in bruhanje, bolečine v čeljustih, mialgija, bolečine v okončinah, artralgija in vročinski oblivi).
English: Only two subjects with severe (Child-Pugh class C) hepatic impairment were dosed with selexipag.
Slovenian: Odmerke seleksipaga sta prejeli le dve osebi z resno (razred C po Child-Pughu) okvaro jeter.
English: Page 28
Slovenian: 28. stran
English: Page 18
Slovenian: 18. stran
English: The patient titration guide to be used by the healthcare professionals during discussions with the patient should contain the following key elements:
Slovenian: Navodilo za titriranje za bolnika uporabljajo zdravstveni delavci med pogovorom z bolnikom.
English: If a dose is missed, it should be taken as soon as possible.
Slovenian: Prekinitve in prenehanje Izpuščeni odmerek je treba dati takoj, ko je mogoče.
English: Hypromellose, propylene glycol, titanium dioxide (E171), carnauba wax and iron oxides (see below).
Slovenian: V filmski oblogi: hipromeloza, propilenglikol, titanov dioksid (E171), karnauba vosek in železovi oksidi (glejte spodaj).
English: Stepping down to a lower dose due to side effects
Slovenian: Zmanjševanje odmerka zaradi neželenih učinkov
English: In the presence of 400/100 mg lopinavir/ritonavir twice daily, a strong CYP3A4 inhibitor, exposure to selexipag increased approximately 2-fold, whereas the exposure to the active metabolite of selexipag did not change.
Slovenian: Zaviralci in induktorji CYP3A4 V prisotnosti 400 mg/100 mg lopinavirja/ritonavirja dvakrat na dan, močnega zaviralca CYP3A4, se je izpostavljenost seleksipagu povečala za približno 2-krat, medtem ko se izpostavljenost aktivnemu presnovku seleksipaga ni spremenila.
English: Hyperthyroidism Thyroid-stimulating Hormone decreased (see section 4.4)
Slovenian: Žilne bolezni vročinski oblivi* hipotenzija (glejte poglavje 4.4)
English: There are treatments available that can help relieve the side effects.
Slovenian: Za lajšanje neželenih učinkov so na voljo zdravila.
English: How should you take Uptravi?
Slovenian: Kako naj jemljem zdravilo Uptravi?
English: No adjustment to the dose regimen is needed in patients with mild hepatic impairment (Child-Pugh class A).
Slovenian: Režima odmerjanja pri bolnikih z blago okvaro jeter (razred A po Child-Pughu) ni treba prilagajati.
English: Page 32
Slovenian: 32. stran
English: The starting dose for Uptravi is 200 micrograms once in the morning and once in the evening.
Slovenian: 200 mikrogramov enkrat zjutraj in enkrat zvečer.
English: Rash Urticaria Erythema
Slovenian: - anemija (nizka raven eritrocitov)
English: Page 31
Slovenian: 31. stran
English: A reduction (up to −0.3 MU/L from a baseline median of 2.5 MU/L) in median thyroid-stimulating hormone was observed at most visits in the selexipag group.
Slovenian: Pri večini obiskov so v skupini s seleksipagom opazili zmanjšanje (do −0,3 M e./l od izhodiščne mediane 2,5 M e./l) mediane ščitnico stimulirajočega hormona.
English: Page 39
Slovenian: 39. stran
English: Page 17
Slovenian: 17. stran
English: Page 27
Slovenian: 27. stran
English: Jaw pain* Myalgia* Arthralgia* Pain in extremity*
Slovenian: mialgija* artralgija*
English: Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease (see section 5.1).
Slovenian: povezano z boleznimi vezivnega tkiva, in PAH, povezano z zdravljeno preprosto prirojeno boleznijo srca (glejte poglavje 5.1).
English: Patients titrating selexipag to an individually tolerated dose (200 micrograms twice daily increments up to 800 micrograms twice daily; N = 33) achieved a statistically significant mean reduction in pulmonary vascular resistance of 30.3% (95% confidence interval [CI]: −44.7%, −12.2%; p = 0.0045) and an increase in cardiac index (mean treatment effect) of 0.48 L/min/m2 (95% CI: 0.13, 0.83) compared to placebo (N = 10).
Slovenian: (95-% interval zaupanja [IZ]: −44,7 %, −12,2 %; p = 0,0045) in povečanje srčnega indeksa (povprečni učinek zdravljenja) za 0,48 l/min/m2 (95-% IZ: 0,13; 0,83) v primerjavi s placebom (N = 10).
English: Page 15
Slovenian: 15. stran
English: Round, light-violet, film-coated tablets with “6” debossed on one side.
Slovenian: Okrogle, svetlo vijolične, filmsko obložene tablete, s "6" vtisnjeno na eni strani.
English: Page 21
Slovenian: 21. stran
English: Page 23
Slovenian: 23. stran
English: Page 33
Slovenian: 33. stran
English: Treatment with selexipag resulted in a placebo-corrected median effect on 6MWD measured at trough (i.e., approximately 12 h post-dose) of 12 m at Week 26 (99% CI: 1, 24 m;
Slovenian: 6MWD, izmerjen tik pred naslednjim odmerkom (tj. približno 12 h po odmerku) pri 12 m v 26. tednu (99-% IZ: 1, 24 m; enostranska vrednost p = 0,0027).
English: Please read the accompanying patient information leaflet before starting treatment.
Slovenian: Pred začetkom zdravljenja preberite priloženo navodilo za uporabo.
English: Page 29
Slovenian: 29. stran
English: Page 5
Slovenian: 5. stran
English: Page 4
Slovenian: 4. stran
English: Page 14
Slovenian: 14. stran
English: Page 6
Slovenian: 6. stran
English: Uptravi 200 microgram Uptravi 400 microgram Uptravi 600 microgram Uptravi 800 microgram Uptravi 1,000 microgram Uptravi 1,200 microgram Uptravi 1,400 microgram Uptravi 1,600 microgram
Slovenian: Uptravi 200 mikrogramov Uptravi 400 mikrogramov Uptravi 600 mikrogramov Uptravi 800 mikrogramov Uptravi 1.000 mikrogramov
English: Page 40
Slovenian: 40. stran
English: Page 10
Slovenian: 10. stran
English: A 1.4- to 1.7-fold increase in exposure (maximum plasma concentration and area under the plasma concentration-time curve) to selexipag and its active metabolite was observed in subjects with severe renal impairment (eGFR < 30 mL/min/1.73 m2).
Slovenian: Pri osebah s hudo okvaro ledvic (eGFR < 30 ml/min/1,73 m2) so opazili 1,4- do 1,7-kratno povečanje izpostavljenosti (največja koncentracija v plazmi in površina pod krivuljo plazemskih koncentracij v odvisnosti od časa) seleksipagu in njegovemu aktivnemu presnovku.
English: Uptravi 400 microgram, 600 microgram, 800 microgram, 1,000 microgram, 1,200 microgram, 1,400 microgram, and 1,600 microgram film-coated tablets are supplied in blister packs of 60 tablets.
Slovenian: Zdravilo Uptravi 400 mikrogramov, 600 mikrogramov, 800 mikrogramov, 1.000 mikrogramov, 1.200 mikrogramov, 1.400 mikrogramov in 1.600 mikrogramov filmsko obložene tablete so na voljo v pretisnih omotih s 60 tabletami.
English: Uptravi 400 microgram, 600 microgram, 800 microgram, 1,000 microgram, 1,200 microgram, 1,400 microgram, and 1,600 microgram film-coated tablets Cartons of 60 film-coated tablets.
Slovenian: Uptravi 400 mikrogramov, 600 mikrogramov, 800 mikrogramov, 1.000 mikrogramov, 1.200 mikrogramov, 1.400 mikrogramov in 1.600 mikrogramov filmsko obložene tablete Škatla s 60 filmsko obloženimi tabletami.
English: Page 19
Slovenian: 19. stran
English: Headache*
Slovenian: - glavobol
English: Page 12
Slovenian: 12. stran
English: - if you have a heart problem, such as: poor blood flow to the heart muscles (severe coronary heart disease or unstable angina); symptoms can include chest pain heart attack within the last 6 months weak heart (decompensated cardiac failure) that is not under close medical observation severe irregular heartbeat defect of the heart valves (inborn or acquired) that causes the heart to work poorly (not related to pulmonary hypertension) - if you have had a stroke within the last 3 months, or any other occurrence that reduced the blood supply to the brain (e.g., transient ischaemic attack) - if you are taking gemfibrozil (medicine used to lower the level of fats [lipids] in the blood)
Slovenian: - če ste v zadnjih 3 mesecih imeli možgansko kap ali drug dogodek, ki je zmanjšal dotok krvi v možgane (npr. tranzitorna ishemična ataka) - če jemljete gemfibrozil (zdravilo za zniževanje ravni maščob (lipidov) v krvi)
English: Page 13
Slovenian: 13. stran
English: Headache Diarrhoea Nausea
Slovenian: Bolezni živčevja glavobol*
English: This stepping-down process will help you find the dose that is right for you, also called your maintenance dose.
Slovenian: S postopkom zmanjšanja boste ugotoviti, kateri odmerek je za vas ustrezen.
English: Page 26
Slovenian: 26. stran
English: General disorders and administration site conditions
Slovenian: Splošne težave in spremembe na mestu aplikacije bolečine
English: Page 9
Slovenian: 9. stran
English: Stepping down
Slovenian: PRETISNI OMOTI
English: Oral use.
Slovenian: • navodilo za uporabo.
English: Exposure to selexipag and the active metabolite at steady state in PAH patients and healthy subjects was similar.
Slovenian: Izpostavljenost seleksipagu in aktivnemu presnovku v stanju dinamičnega ravnovesja pri bolnikih s
English: Contents
Slovenian: Opombe
English: Selexipag is hydrolysed to its active metabolite in the liver and in the intestine by carboxylesterases.
Slovenian: Seleksipag se v jetrih in v črevesju s karboksilesterazami hidrolizira v svoj aktivni presnovek.
English: Each film-coated tablet contains 200 micrograms of selexipag
Slovenian: Ena filmsko obložena tableta vsebuje 200 mikrogramov seleksipaga.
English: Common side effects (may affect up to 1 in 10 people) - Anaemia (low red blood cell levels) - Hyperthyroidism (overactive thyroid gland) - Decreased appetite - Weight loss - Hypotension (low blood pressure) - Stomach pain - Pain - Changes in some blood test results including those measuring blood cell counts or your thyroid function - Rashes, including hives, may cause a burning or stinging sensation and skin redness
Slovenian: - bolečine v trebuhu - bolečine - spremembe vrednosti nekaterih krvnih preiskav, vključno s tistimi, ki merijo število celic ali delovanje ščitnice - izpuščaji, vključno s koprivnico, lahko povzročijo pekoč občutek ali zbadanje in rdečino kože
English: Musculoskeletal and connective tissue disorders
Slovenian: Bolezni mišično skeletnega sistema in vezivnega tkiva bolečine v čeljustih*
English: Page 3
Slovenian: 3. stran
English: Uptravi 800 microgram film-coated tablets Round, green, film-coated tablets with “8” debossed on one side.
Slovenian: Uptravi 800 mikrogramov filmsko obložene tablete Okrogle, zelene, filmsko obložene tablete, z "8" vtisnjeno na eni strani.
English: Hypromellose, propylene glycol, titanium dioxide (E171),
Slovenian: hipromeloza propilenglikol titanov dioksid (E171)
English: Check with your doctor if you are not sure or have any questions.
Slovenian: Če ste negotovi ali imate vprašanja, se posvetujte z zdravnikom.
English: Nasopharyngitis (of non-infectious origin)
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora nazofaringitis (neinfekcijskega izvora)
English: In a Phase 3 placebo-controlled study in patients with PAH, hyperthyroidism was reported for 1.6% of patients in the selexipag group, compared to no case in the placebo group (see section 4.4).
Slovenian: bolnikov v skupini s seleksipagom v primerjavi z nobenim primerom v skupini s placebom (glejte poglavje 4.4).
English: Uptravi 400 microgram film-coated tablets: Round, red, film-coated tablets with “4” marked on one side.
Slovenian: Zdravilo Uptravi 400 mikrogramov filmsko obložene tablete: Okrogle, rdeče, filmsko obložene tablete, s "4" vtisnjeno na eni strani.
English: Uptravi 800 microgram film-coated tablets Each film-coated tablet contains 800 micrograms of selexipag.
Slovenian: Uptravi 800 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 800 mikrogramov seleksipaga.
English: Uptravi 1,000 microgram film-coated tablets Round, orange, film-coated tablets with “10” debossed on one side.
Slovenian: Uptravi 1.000 mikrogramov filmsko obložene tablete Okrogle, oranžne, filmsko obložene tablete, z "10" vtisnjeno na eni strani.
English: Cartons of 10 or 60 film-coated tablets, and 60 or 140 film-coated tablets (titration packs).
Slovenian: 60 tabletami in 60 ali 140 tabletami (pakiranja za povečevanje odmerka).
English: Uptravi 200 microgram film-coated tablets Round, light-yellow, film-coated tablets with “2” debossed on one side.
Slovenian: Uptravi 200 mikrogramov filmsko obložene tablete Okrogle, svetlo rumene, filmsko obložene tablete, z "2" vtisnjeno na eni strani.
English: Sinus tachycardia
Slovenian: Srčne bolezni sinusna tahikardija
English: Uptravi should not be used during breast-feeding.
Slovenian: Med zdravljenjem z zdravilom Uptravi je treba prenehati z dojenjem.
English: iron oxide red (E172), iron oxide black (E172), carnauba wax.
Slovenian: rumeni železov oksid (E172) karnauba vosek
English: Uptravi 200 microgram film-coated tablets contain iron oxide yellow (E172).
Slovenian: Zdravilo Uptravi 200 mikrogramov filmsko obložene tablete vsebujejo rumeni železov oksid (E172).
English: The dose was increased at weekly intervals by increments of 200 micrograms given twice daily to determine the individualised maintenance dose (200-1,600 micrograms twice daily).
Slovenian: Bolniki so bili randomizirani za prejemanje placeba (N = 582) ali seleksipaga (N = 574) dvakrat na dan. Odmerek se je postopoma povečeval v tedenskih intervalih po 200 mikrogramov dvakrat na dan za določitev individualiziranega vzdrževalnega odmerka (200-1.600 mikrogramov dvakrat na dan).
English: Uptravi 800 microgram film-coated tablets: Round, green, film-coated tablets with “8” marked on one side.
Slovenian: Zdravilo Uptravi 800 mikrogramov filmsko obložene tablete: Okrogle, zelene, filmsko obložene tablete, z "8" vtisnjeno na eni strani.
English: Uptravi 200 microgram tablets Uptravi 400 microgram tablets Uptravi 600 microgram tablets Uptravi 800 microgram tablets Uptravi 1,000 microgram tablets Uptravi 1,200 microgram tablets Uptravi 1,400 microgram tablets Uptravi 1,600 microgram tablets selexipag
Slovenian: Uptravi 200 mikrogramov tablete Uptravi 400 mikrogramov tablete Uptravi 600 mikrogramov tablete Uptravi 800 mikrogramov tablete Uptravi 1.000 mikrogramov tablete Uptravi 1.200 mikrogramov tablete Uptravi 1.400 mikrogramov tablete Uptravi 1.600 mikrogramov tablete seleksipag
English: Uptravi 1,400 microgram film-coated tablets contain iron oxide yellow (E172).
Slovenian: Zdravilo Uptravi 1.400 mikrogramov filmsko obložene tablete vsebujejo rumeni železov oksid (E172).
English: Uptravi 1,400 microgram film-coated tablets Round, dark-yellow, film-coated tablets with “14” debossed on one side.
Slovenian: Uptravi 1.400 mikrogramov filmsko obložene tablete Okrogle, temno rumene, filmsko obložene tablete, s "14" vtisnjeno na eni strani.
English: Uptravi 1,000 microgram film-coated tablets: Round, orange, film-coated tablets with “10” marked on one side.
Slovenian: Zdravilo Uptravi 1.000 mikrogramov filmsko obložene tablete: Okrogle, oranžne, filmsko obložene tablete, z "10" vtisnjeno na eni strani.
English: Uptravi 1,200 microgram film-coated tablet
Slovenian: Uptravi 1.200 mikrogramov filmsko obložene tablete
English: Skin and subcutaneous tissue disorders
Slovenian: Bolezni kože in podkožja izpuščaj urtikarija eritem
English: Uptravi 200 microgram film-coated tablets selexipag
Slovenian: Uptravi 200 mikrogramov filmsko obložene tablete seleksipag
English: Uptravi 200 microgram film-coated tablets Each film-coated tablet contains 200 micrograms of selexipag.
Slovenian: Uptravi 200 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 200 mikrogramov seleksipaga.
English: No accumulation in plasma, either of parent compound or active metabolite, occurred after multiple-dose administration.
Slovenian: Po dajanju večkratnih odmerkov se nista niti izhodna snov niti aktivni presnovek kopičila v plazmi.
English: Uptravi 800 microgram film-coated tablets contain iron oxide yellow and iron oxide black (E172).
Slovenian: Zdravilo Uptravi 800 mikrogramov filmsko obložene tablete vsebujejo rumeni železov oksid in črni železov oksid (E172).
English: Uptravi 800 microgram film-coated tablets.
Slovenian: Uptravi 800 mikrogramov filmsko obložene tablete:
English: Uptravi 1,600 microgram film-coated tablets Round, brown, film-coated tablets with “16” debossed on one side.
Slovenian: Uptravi 1.600 mikrogramov filmsko obložene tablete Okrogle, rjave, filmsko obložene tablete, s "16" vtisnjeno na eni strani.
English: Uptravi 400 microgram film-coated tablets Each film-coated tablet contains 400 micrograms of selexipag.
Slovenian: Uptravi 400 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 400 mikrogramov seleksipaga.
English: Uptravi 1,600 microgram film-coated tablets: Round, brown, film-coated tablets with “16” marked on one side.
Slovenian: Zdravilo Uptravi 1.600 mikrogramov filmsko obložene tablete: Okrogle, rjave, filmsko obložene tablete, s "16" vtisnjeno na eni strani.
English: Both in healthy subjects and PAH patients, after oral administration, exposure at steady state to the active metabolite is approximately 3- to 4-fold higher than to the parent compound.
Slovenian: je po peroralni uporabi izpostavljenost aktivnemu presnovku v stanju dinamičnega ravnovesja približno 3- do 4-krat večja, kot izpostavljenost izhodni snovi.
English: Nasal congestion
Slovenian: kongestija nosne sluznice
English: The pharmacokinetics of selexipag and its active metabolite are not affected by warfarin.
Slovenian: Varfarin ni vplival na farmakokinetiko seleksipaga in njegovega aktivnega presnovka.
English: Uptravi 1,600 microgram film-coated tablets contain iron oxide black, iron oxide red and iron oxide yellow (E172).
Slovenian: Zdravilo Uptravi 1.600 mikrogramov filmsko obložene tablete vsebujejo črni železov oksid, rdeči železov oksid in rumeni železov oksid (E172).
English: Uptravi 600 microgram film-coated tablets
Slovenian: Uptravi 600 mikrogramov filmsko obložene tablete
English: Uptravi 600 microgram film-coated tablets contain iron oxide red and iron oxide black (E172).
Slovenian: Zdravilo Uptravi 600 mikrogramov filmsko obložene tablete vsebujejo rdeči železov oksid in črni železov oksid (E172).
English: Uptravi 1,200 microgram film-coated tablets Each film-coated tablet contains 1,200 micrograms of selexipag.
Slovenian: Uptravi 1.200 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 1.200 mikrogramov seleksipaga.
English: Notes
Slovenian: ZDRAVILA
English: Uptravi 1,400 microgram film-coated tablets: Round, dark-yellow, film-coated tablets with “14” marked on one side.
Slovenian: Zdravilo Uptravi 1.400 mikrogramov filmsko obložene tablete: Okrogle, temno rumene, filmsko obložene tablete, s "14" vtisnjeno na eni strani.
English: Uptravi 600 microgram film-coated tablets: Round, light-violet, film-coated tablets with “6” marked on one side.
Slovenian: Zdravilo Uptravi 600 mikrogramov filmsko obložene tablete: Okrogle, svetlo vijolične, filmsko obložene tablete, s "6" vtisnjeno na eni strani.
English: Uptravi 600 microgram film-coated tablets Each film-coated tablet contains 600 micrograms of selexipag.
Slovenian: Uptravi 600 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 600 mikrogramov seleksipaga.
English: Uptravi 1,000 microgram film-coated tablets contain iron oxide red and iron oxide yellow (E172).
Slovenian: Zdravilo Uptravi 1.000 mikrogramov filmsko obložene tablete vsebujejo rdeči železov oksid in rumeni železov oksid (E172).
English: Uptravi 200 microgram film-coated tablets: Round, light-yellow, film-coated tablets with “2” marked on one side.
Slovenian: Zdravilo Uptravi 200 mikrogramov filmsko obložene tablete: Okrogle, svetlo rumene, filmsko obložene tablete, z "2" vtisnjeno na eni strani.
English: Uptravi 1,200 microgram film-coated tablets contain iron oxide black and iron oxide red (E172).
Slovenian: Zdravilo Uptravi 1.200 mikrogramov filmsko obložene tablete vsebujejo črni železov oksid in rdeči železov oksid (E172).
English: In the presence of 400/100 mg lopinavir/ritonavir twice daily, a strong OATP (OATP1B1 and OATP1B3) and P-gp inhibitor, exposure to selexipag increased approximately 2-fold, whereas the exposure to the active metabolite of selexipag did not change.
Slovenian: (OATP1B1 in OATP1B3) in P-gp, se je izpostavljenost seleksipagu povečala za približno 2-krat, medtem ko se izpostavljenost aktivnemu presnovku seleksipaga ni spremenila.
English: Uptravi 1,400 microgram film-coated tablets Each film-coated tablet contains 1,400 micrograms of selexipag.
Slovenian: Uptravi 1.400 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 1.400 mikrogramov seleksipaga.
English: Uptravi 400 microgram film-coated tablet
Slovenian: Uptravi 400 mikrogramov filmsko obložene tablete
English: Uptravi 1,000 microgram film-coated tablets Each film-coated tablet contains 1,000 micrograms of selexipag.
Slovenian: Uptravi 1.000 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 1.000 mikrogramov seleksipaga.
English: In the tablet core:
Slovenian: Vsebovati mora naslednje ključne elemente:
English: Uptravi 1,200 microgram film-coated tablets: Round, dark-violet, film-coated tablets with “12” marked on one side.
Slovenian: Zdravilo Uptravi 1.200 mikrogramov filmsko obložene tablete: Okrogle, temno vijolične, filmsko obložene tablete, z "12" vtisnjeno na eni strani.
English: Uptravi 1,000 microgram film-coated tablets.
Slovenian: Uptravi 1.000 mikrogramov filmsko obložene tablete:
English: Hypromellose, propylene glycol, titanium dioxide (E171), iron oxide red (E172), iron oxide yellow (E172), carnauba wax.
Slovenian: hipromeloza propilenglikol titanov dioksid (E171) rumeni železov oksid (E172) karnauba vosek
English: Uptravi 1,400 microgram film-coated tablets.
Slovenian: Uptravi 1.400 mikrogramov filmsko obložene tablete:
English: Haemoglobin decrease
Slovenian: Zmanjšanje vrednosti hemoglobina
English: Uptravi 1,600 microgram film-coated tablets Each film-coated tablet contains 1,600 micrograms of selexipag.
Slovenian: Uptravi 1.600 mikrogramov filmsko obložene tablete Ena filmsko obložena tableta vsebuje 1.600 mikrogramov seleksipaga.
English: Your doctor may step you down to a lower dose.
Slovenian: Morda bo moral vaš zdravnik odmerek znižati.